003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,990.00
−1.36%Leverage
- Debt / equity
- 0.71x
- Net debt / equity
- 0.62x
- Debt / assets
- 0.33x
- Debt / EBITDA
- -4.62x
- Net debt / EBITDA
- -4.04x
Liquidity & coverage
- Current ratio
- 1.12x
- Quick ratio
- 0.62x
- Cash ratio
- 0.32x
- Interest coverage
- -0.01x
- EBITDA / interest
- -6.06x
- Working capital
- KRW 25.7B
Cash & dividend
- FCF / debt
- 0.01x
- Cash flow / debt
- 0.13x
- Dividend per share
- KRW 250
- Dividend yield
- 3.1%
- Dividend growth 1y
- -16.7%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026